Persistence of the developmental language disorder diagnosis, neurodevelopmental trajectories and attendance at offered interventions
Acta Paediatrica · 2025-05 · 114 (5) · 829-837
DOI: 10.1111/apa.17494 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Paediatrica, online erschienen am 10.11.2024. Verfasst von Ulrika Schachinger Lorentzon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Gillberg Neuropsychiatry Centre, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Goteborg, Sweden. Hauptthemen laut MEDLINE: Language Development Disorders, Neurodevelopmental Disorders, Neuropsychological Tests, Language Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AnnMari och Per Ahlqvists Stiftelse, Västra Götalandsregionen, Linnéa och Josef Carlssons Stiftelse.
Abstract (Originalsprache)
Aim
To study the diagnostic stability of developmental language disorders, other neurodevelopmental disorders and interventions received until age 6 years in children who screened positive for language delay, but not for autism, at age 2.5 years.
Methods
In 2016, in Gothenburg, Sweden, 100 monolingual or multilingual children underwent language assessment at a mean age of 2.9 years. At age 6 years, 85 of these children underwent language assessment. A review of paediatric records was performed after the clinical assessment to obtain information about other neurodevelopmental disorders and interventions received.
Results
At age 6 years, 74/85 (87%) of the children had persistent language disorders, and 20/85 (24%) had been diagnosed with at least one additional neurodevelopmental disorder. Five of them had autism. In general, families only attended half of the offered intervention sessions irrespective of intervention type and no difference between monolingual and multilingual families was found.
Conclusions
The persistence of language disorder and the presence of later additional neurodevelopmental disorders highlight the importance of longitudinal and multidisciplinary monitoring of children with delayed language development. Further studies and analyses are warranted to investigate the reasons behind the poor attendance rate for interventions offered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gillberg Neuropsychiatry Centre, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Goteborg, Sweden.
- Paediatric Speech and Language Pathology Clinic, Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Child and Adolescent Neuropsychiatry Unit, Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
ORCID-Profile: Ulrika Schachinger Lorentzon, Eva Billstedt, Christopher Gillberg, Carmela Miniscalco
Förderung
- AnnMari och Per Ahlqvists Stiftelse
- Västra Götalandsregionen
- Linnéa och Josef Carlssons Stiftelse
- Drottning Silvias barnsjukhus
- Stiftelsen Clas Groschinskys Minnesfond
- Stiftelsen Solstickan
Zitieren
APA
Schachinger Lorentzon, U., Billstedt, E., Gillberg, C., & Miniscalco, C. (2025). Persistence of the developmental language disorder diagnosis, neurodevelopmental trajectories and attendance at offered interventions. Acta Paediatrica, 114(5), 829-837. https://doi.org/10.1111/apa.17494
Vancouver
Schachinger Lorentzon U, Billstedt E, Gillberg C, Miniscalco C. Persistence of the developmental language disorder diagnosis, neurodevelopmental trajectories and attendance at offered interventions. Acta Paediatrica. 2025;114(5):829-837. doi:10.1111/apa.17494
BibTeX
@article{SchachingerLorentzon2025,
author = {Schachinger Lorentzon, Ulrika and Billstedt, Eva and Gillberg, Christopher and Miniscalco, Carmela},
title = {Persistence of the developmental language disorder diagnosis, neurodevelopmental trajectories and attendance at offered interventions},
journal = {Acta Paediatrica},
year = {2025},
volume = {114},
number = {5},
pages = {829--837},
doi = {10.1111/apa.17494}
}
EUVIMED